World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
68
Citations
15265
World Ranking
2607
National Ranking
228

Michele Bombardieri publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Michele Bombardieri sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 342 publications — 72nd percentile

72% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Michele Bombardieri D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Michele Bombardieri sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 68 D-Index — 49th percentile

49% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Michele Bombardieri is affiliated with Queen Mary University of London in the United Kingdom. Their research primarily focuses on the field of Medicine, with subfields including Rheumatology, Pathology and Forensic Medicine, and Physiology.

The scientist's work encompasses multiple main topics, notably Rheumatoid Arthritis Research and Therapies, Lymphoma Diagnosis and Treatment, Systemic Lupus Erythematosus Research, Salivary Gland Disorders and Functions, and Systemic Sclerosis and Related Diseases.

Michele Bombardieri has published research in notable venues, with a concentration of work appearing in the Annals of the Rheumatic Diseases. The following recent papers illustrate their research output:

  • OP0077 SYNOVIAL RNA-SEQ ANALYSIS OF THE R4RA TRIAL IDENTIFIES SIGNATURES OF TREATMENT RESISTANCE AND REFRACTORY STATE IN RHEUMATOID ARTHRITIS, 2022, Annals of the Rheumatic Diseases
  • OP0085 CELL LINEAGE-SPECIFIC TRANSCRIPT DECONVOLUTION OF SYNOVIAL BIOPSIES FROM THE R4RA TRIAL IDENTIFIES CELL POPULATIONS ASSOCIATED WITH RESPONSE TO RITUXIMAB AND TOCILIZUMAB, 2022, Annals of the Rheumatic Diseases
  • POS0265 ESTABLISHING CONSISTENCY IN THE DIGITAL IMAGING ANALYSIS OF HISTOLOGICAL PARAMETERS IN SJOGREN'S DISEASE, 2024, Annals of the Rheumatic Diseases

Their collaboration network includes frequent co-authors such as A. Surace, Elisabetta Sciacca, K. Goldmann, C. Cubuk, and G. Giorli.

Best Publications

  • Lactate Regulates Metabolic and Pro-inflammatory Circuits in Control of T Cell Migration and Effector Functions.

    Robert Haas;Joanne Smith;Vidalba Rocher-Ros;Suchita Nadkarni

  • Ectopic lymphoid-like structures in infection, cancer and autoimmunity

    Costantino Pitzalis;Gareth Wyn Jones;Michele Bombardieri;Simon Arnett Jones

  • Ectopic Lymphoid Structures Support Ongoing Production of Class-Switched Autoantibodies in Rheumatoid Synovium

    Frances Humby;Michele Bombardieri;Antonio Manzo;Stephen Kelly

  • Lactate Buildup at the Site of Chronic Inflammation Promotes Disease by Inducing CD4+ T Cell Metabolic Rewiring.

    Valentina Pucino;Valentina Pucino;Michelangelo Certo;Michelangelo Certo;Vinay Bulusu;Danilo Cucchi

  • Molecular Portraits of Early Rheumatoid Arthritis Identify Clinical and Treatment Response Phenotypes

    Myles J. Lewis;Michael R. Barnes;Michael R. Barnes;Kevin Blighe;Katriona Goldmann

  • Rituximab versus tocilizumab in rheumatoid arthritis: synovial biopsy-based biomarker analysis of the phase 4 R4RA randomized trial

    Unknown

  • Synovial cellular and molecular signatures stratify clinical response to csDMARD therapy and predict radiographic progression in early rheumatoid arthritis patients

    Frances Humby;Myles Lewis;Nandhini Ramamoorthi;Jason A Hackney

  • Overexpression of interleukin-23, but not interleukin-17, as an immunologic signature of subclinical intestinal inflammation in ankylosing spondylitis

    Francesco Ciccia;Michele Bombardieri;Alfonso Principato;AnnaRita Giardina

  • Rituximab versus tocilizumab in anti-TNF inadequate responder patients with rheumatoid arthritis (R4RA): 16-week outcomes of a stratified, biopsy-driven, multicentre, open-label, phase 4 randomised controlled trial

    Frances Humby;Frances Humby;Patrick Durez;Patrick Durez;Maya H Buch;Maya H Buch;Myles J Lewis;Myles J Lewis

  • CXCL13, CCL21, and CXCL12 expression in salivary glands of patients with Sjögren's syndrome and MALT lymphoma: Association with reactive and malignant areas of lymphoid organization

    Francesca Barone;Michele Bombardieri;Manuela Maria Rosado;Peter Roger Morgan

  • Ectopic Lymphoid Neogenesis in Rheumatic Autoimmune Diseases

    Michele Bombardieri;Myles Lewis;Costantino Pitzalis

  • Lactate at the crossroads of metabolism, inflammation, and autoimmunity

    Valentina Pucino;Michele Bombardieri;Costantino Pitzalis;Claudio Mauro

  • Decrease of anti-cyclic citrullinated peptide antibodies and rheumatoid factor following anti-TNFα therapy (infliximab) in rheumatoid arthritis is associated with clinical improvement

    C Alessandri;M Bombardieri;N Papa;M Cinquini

  • IL-22 regulates lymphoid chemokine production and assembly of tertiary lymphoid organs.

    Francesca Barone;Francesca Barone;Saba Nayar;Saba Nayar;Joana Campos;Joana Campos;Thomas Cloake;Thomas Cloake

  • Ultrasound-guided synovial biopsy: a safe, well-tolerated and reliable technique for obtaining high-quality synovial tissue from both large and small joints in early arthritis patients

    S Kelly;F Humby;A Filer;N Ng

  • Influence of geolocation and ethnicity on the phenotypic expression of primary Sjögren's syndrome at diagnosis in 8310 patients: a cross-sectional study from the Big Data Sjögren Project Consortium.

    Pilar Brito-Zerón;Pilar Brito-Zerón;Nihan Acar-Denizli;Margit Zeher;Astrid Rasmussen

  • Activation-Induced Cytidine Deaminase Expression in Follicular Dendritic Cell Networks and Interfollicular Large B Cells Supports Functionality of Ectopic Lymphoid Neogenesis in Autoimmune Sialoadenitis and MALT Lymphoma in Sjögren’s Syndrome

    Michele Bombardieri;Francesca Barone;Frances Humby;Stephen Kelly

  • Single cell cloning and recombinant monoclonal antibodies generation from RA synovial B cells reveal frequent targeting of citrullinated histones of NETs

    Elisa Corsiero;Michele Bombardieri;Emanuela Carlotti;Federico Pratesi

  • Secondary and ectopic lymphoid tissue responses in rheumatoid arthritis: from inflammation to autoimmunity and tissue damage/remodeling.

    Antonio Manzo;Michele Bombardieri;Frances Humby;Costantino Pitzalis

  • Unique expansion of IL-21+ Tfh and Tph cells under control of ICOS identifies Sjögren’s syndrome with ectopic germinal centres and MALT lymphoma

    Elena Pontarini;William James Murray-Brown;Cristina Croia;Davide Lucchesi

  • Increased circulating levels and salivary gland expression of interleukin-18 in patients with Sjögren's syndrome: relationship with autoantibody production and lymphoid organization of the periductal inflammatory infiltrate.

    Michele Bombardieri;Francesca Barone;Valerio Pittoni;Cristiano Alessandri

  • Role of anti-cyclic citrullinated peptide antibodies in discriminating patients with rheumatoid arthritis from patients with chronic hepatitis C infection-associated polyarticular involvement.

    Michele Bombardieri;Cristiano Alessandri;Giancarlo Labbadia;Cristina Iannuccelli

Frequent Co-Authors

Costantino Pitzalis
Costantino Pitzalis Queen Mary University of London
Guido Valesini
Guido Valesini Sapienza University of Rome
Paul Emery
Paul Emery University of Leeds
Christopher D. Buckley
Christopher D. Buckley University of Oxford
David A. Isenberg
David A. Isenberg University College London
Luca Quartuccio
Luca Quartuccio University of Udine
Peter C. Taylor
Peter C. Taylor University of Oxford
Hendrika Bootsma
Hendrika Bootsma University Medical Center Groningen
Fabiola Atzeni
Fabiola Atzeni University of Messina
Iain B. McInnes
Iain B. McInnes University of Glasgow

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring related healthcare degrees can open diverse career opportunities. Nursing roles, especially Nurse Practitioner (NP) programs, offer a practical route into patient care with a science focus. If you're considering easier entry points, the easiest np program options provide flexible and accessible pathways to earn your credentials.

Specializing further, the psychiatric mental health nurse practitioner field blends immunological insights with mental health care. Programs like the best online psychiatric mental health nurse practitioner programs ensure strong clinical placement rates, enhancing practical experience and employability.

Affordability is a key consideration when choosing a program. For budget-conscious students, discovering the cheapest pmhnp programs online can make advanced education more accessible without compromising quality.

Finally, understanding the financial prospects is crucial. The dnp salary by specialty highlights how salaries vary across states and specialties, helping students align their education with career goals that offer competitive compensation.

Best Scientists Citing Michele Bombardieri

Trending Scientists

Recently Published Articles